Connecting Molecules to Medicine™
See What Makes Nexus Pharmaceuticals Different
Through our commitment to innovative R&D, Nexus Pharmaceuticals identifies off-patent and difficult to formulate molecules that can be developed, improved upon, and commercialized to advance industry standards and deliver on critical medical needs.
Is your pharmaceutical manufacturer a certified diverse supplier?
New State-of-the-Art Manufacturing Facility located in Pleasant Prairie, WI
Commitment to Quality
From Molecules to Medicine
Opening in Summer 2021
State-of-the-Art Sterile Injectable Manufacturing Facility
Located in Pleasant Prairie, Wisconsin, we broke ground in 2019 to build Project Tomorrow, a state-of-the-art sterile injectable manufacturing facility to support the production and supply of injectable drugs in various therapeutic areas including anesthesiology, oncology, cardiology, and neurology. We plan to invest $250 million over the next ten years and create over 400 jobs in total.
News
Nexus Pharmaceuticals Celebrates Grand Opening of New Facility
Industry Partnership on EMERPHED™ (Ephedrine Sulfate) Study Bolsters Opportunity for Research and Education | Comparison of EMERPHED™ (Ephedrine Sulfate) Injection with Current Concentrated Ephedrine Products in Simulated Clinical Settings
Industry Partnership on EMERPHED™ (Ephedrine Sulfate)
Industry Partnership on EMERPHED™ (Ephedrine Sulfate) Study Bolsters Opportunity for Research and Education | Comparison of EMERPHED™ (Ephedrine Sulfate) Injection with Current Concentrated Ephedrine Products in Simulated Clinical Settings
Parkside Athletics Announces Partnership with Nexus
Nexus is proud to partner with the University of Wisconsin-Parkside and Parkside Athletics in support of their #RangerVision2020 campaign to secure a brighter future for student-athletes, the Parkside Athletics program, and the Wisconsin community.
Find out what we’re about
Discover more about Nexus Pharmaceuticals and get in touch today!
Lincolnshire, IL 60069 United States